Shrinkage of Pegylated and Non-Pegylated Liposomes in Serum

Colloids and Surfaces B: Biointerfaces - Netherlands
doi 10.1016/j.colsurfb.2013.10.009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

PEGylated Perylenemonoimide-Dithienylethene for Super-Resolution Imaging of Liposomes

English

Accelerated Blood Clearance of PEGylated Liposomes After Repeated Injection

Drug Delivery System
Pharmaceutical Science
2004English

Are PEGylated Liposomes Better Than Conventional Liposomes? A Special Case for Vincristine

Drug Delivery
MedicinePharmaceutical Science
2015English

“Smart” Drug Carriers: PEGylated TATp-Modified pH-Sensitive Liposomes

Journal of Liposome Research
Pharmaceutical Science
2007English

In Vivo Quantitative Understanding of PEGylated Liposomes Influence on Brain Delivery of Diphenhydramine

English

Two Phase II Trials of Temozolomide With Interferon-Α2b (Pegylated and Non-Pegylated) in Patients With Recurrent Glioblastoma Multiforme

British Journal of Cancer
Cancer ResearchOncology
2009English

Glutathione PEGylated Liposomes: Pharmacokinetics and Delivery of Cargo Across the Blood–brain Barrier in Rats

Journal of Drug Targeting
Pharmaceutical Science
2014English

Efficacy and Safety of Non-Pegylated Liposomal Doxorubicin in Metastatic Breast Cancer Therapy

OnCOReview
Oncology
2017English

Skin Transport of Hydrophilic Compound-Loaded PEGylated Lipid Nanocarriers: Comparative Study of Liposomes, Niosomes, and Solid Lipid Nanoparticles

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy